Valproic acid inhibits neural progenitor cell death by activation of NF-B signaling pathway and up-regulation of Bcl-XL

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Go, Hyo Sang ^a   Seo, Jung Eun ^a   Kim, Ki Chan ^a   Han, So Min ^a   Kim, Pitna Kim ^b   Kang, Young Sun ^c   Han, Seol Heui ^b   Shin, Chan Young ^b   Ko, Kwang Ho ^a  

^a Seoul National University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BCL XL; SYNAPTOTAGMIN I; VALPROIC ACID; PROTEIN BCL X;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL CULTURE; CELL DEATH; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; FETAL VALPROATE SYNDROME; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; INFANTILE AUTISM; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CELL PROTECTION; DRUG EFFECT; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PREGNANCY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CYTOPROTECTION; FEMALE; NEURAL STEM CELLS; NEUROGENESIS; NF-KAPPA B; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VALPROIC ACID;

EID: 79959790184     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-48     Document Type: Article

References (53)

1. Regressive events in neurogenesis. Cowan WM, Fawcett JW, O'Leary DD, Stanfield BB, Science 1984 225 1258 1265 10.1126/science.6474175 6474175 (Pubitemid 14026328)
2. History of the discovery of neuronal death in embryos. Hamburger V, J Neurobiol 1992 23 1116 1123 10.1002/neu.480230904 1469378
3. Apoptosis and Bcl-2 oncoprotein expression in the human fetal central nervous system. Chan WY, Yew DT, Anat Rec 1998 252 165 175 10.1002/(SICI)1097- 0185(199810)252:2<165::AID-AR2>3.0.CO;2-2 9776071 (Pubitemid 28440901)
4. Postnatal development of the rat striatum - a study using in situ DNA end labeling technique. Maciejewska B, Lipowska M, Kowianski P, Domaradzka-Pytel B, Morys J, Acta Neurobiol Exp (Wars) 1998 58 23 28 (Pubitemid 28129314)
5. Cell proliferation and death: morphological evidence during corticogenesis in the developing human brain. Simonati A, Tosati C, Rosso T, Piazzola E, Rizzuto N, Microsc Res Tech 1999 45 341 352 10.1002/(SICI)1097- 0029(19990615)45:6<341::AID-JEMT2>3.0.CO;2-U 10402262 (Pubitemid 29321049)
6. Development of layer I of the human cerebral cortex after midgestation: architectonic findings, immunocytochemical identification of neurons and glia, and in situ labeling of apoptotic cells. Spreafico R, Arcelli P, Frassoni C, Canetti P, Giaccone G, Rizzuti T, Mastrangelo M, Bentivoglio M, J Comp Neurol 1999 410 126 142 10.1002/(SICI)1096-9861(19990719)410:1<126::AID-CNE11>3. 0.CO;2-5 10397400 (Pubitemid 29284225)
7. Neuronal cell death in nervous system development, disease, and injury (Review). Martin LJ, Int J Mol Med 2001 7 455 478 11295106
8. Apoptosis and neurologic disease. Honig LS, Rosenberg RN, Am J Med 2000 108 317 330 10.1016/S0002-9343(00)00291-6 11014725 (Pubitemid 30110461)
9. Programmed cell death in animal development. Jacobson MD, Weil M, Raff MC, Cell 1997 88 347 354 10.1016/S0092-8674(00)81873-5 9039261 (Pubitemid 27131376)
10. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Han BH, DeMattos RB, Dugan LL, Kim-Han JS, Brendza RP, Fryer JD, Kierson M, Cirrito J, Quick K, Harmony JA, et al. Nat Med 2001 7 338 343 10.1038/85487 11231633 (Pubitemid 32224350)
11. Ethanol-induced apoptotic neurodegeneration in the developing brain. Olney JW, Ishimaru MJ, Bittigau P, Ikonomidou C, Apoptosis 2000 5 515 521 10.1023/A:1009685428847 11303910 (Pubitemid 32182549)
12. Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Olney JW, Farber NB, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C, Environ Health Perspect 2000 108 Suppl 3 383 388 10852832 (Pubitemid 30466160)
13. EGF signaling activates proliferation and blocks apoptosis of mouse and human intestinal stem/progenitor cells in long-term monolayer cell culture. Suzuki A, Sekiya S, Gunshima E, Fujii S, Taniguchi H, Lab Invest 2010 90 1425 1436 10.1038/labinvest.2010.150 20714325
14. Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells. Duval D, Trouillas M, Thibault C, Dembele D, Diemunsch F, Reinhardt B, Mertz AL, Dierich A, Boeuf H, Cell Death Differ 2006 13 564 575 10.1038/sj.cdd.4401789 16311515
15. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G, J Biol Chem 2001 276 31674 31683 10.1074/jbc.M104309200 11418608
16. Valproic acid, a molecular lead to multiple regulatory pathways. Kostrouchova M, Kostrouch Z, Folia Biol (Praha) 2007 53 37 49 (Pubitemid 46546777)
17. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK, J Neurochem 1999 72 879 882 9930766 (Pubitemid 29055256)
18. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Kim KC, Kim P, Go HS, Choi CS, Yang SI, Cheong JH, Shin CY, Ko KH, Toxicol Lett 2011 201 137 142 10.1016/j.toxlet.2010.12.018 21195144
19. Neurotrophin channeling of neural progenitor cell differentiation. Benoit BO, Savarese T, Joly M, Engstrom CM, Pang L, Reilly J, Recht LD, Ross AH, Quesenberry PJ, J Neurobiol 2001 46 265 280 10.1002/1097-4695(200103)46: 4<265::AID-NEU1007>3.0.CO;2-B 11180154 (Pubitemid 32167856)
20. Increased proliferation and gliogenesis of cultured rat neural progenitor cells by lipopolysaccharide-stimulated astrocytes. Go HS, Shin CY, Lee SH, Jeon SJ, Kim KC, Choi CS, Ko KH, Neuroimmunomodulation 2009 16 365 376 10.1159/000228911 19609085
21. Nup98 is a mobile nucleoporin with transcription-dependent dynamics. Griffis ER, Altan N, Lippincott-Schwartz J, Powers MA, Mol Biol Cell 2002 13 1282 1297 10.1091/mbc.01-11-0538 11950939 (Pubitemid 34309623)
22. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Schreiber E, Harshman K, Kemler I, Malipiero U, Schaffner W, Fontana A, Nucleic Acids Res 1990 18 5495 5503 10.1093/nar/18.18.5495 2216722
23. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nelson JD, Denisenko O, Bomsztyk K, Nat Protoc 2006 1 179 185 10.1038/nprot.2006.27 17406230
24. Brain-derived neurotrophic factor enhances Bcl-xL expression through protein kinase casein kinase 2-activated and nuclear factor kappa B-mediated pathway in rat hippocampus. Chao CC, Ma YL, Lee EH, Brain Pathol 2011 21 150 162 10.1111/j.1750-3639.2010.00431.x 20731656
25. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Oltvai ZN, Milliman CL, Korsmeyer SJ, Cell 1993 74 609 619 10.1016/0092-8674(93)90509-O 8358790 (Pubitemid 23259742)
26. Novel roles for the NF-kappaB signaling pathway in regulating neuronal function. Boersma MC, Meffert MK, Sci Signal 2008 1 e7 10.1126/stke.16pe7 18272467
27. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D, Nature 1995 376 167 170 10.1038/376167a0 7603567
28. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM, J Cereb Blood Flow Metab 2011 31 52 57 10.1038/jcbfm.2010.195 20978517
29. Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Faraco G, Pittelli M, Cavone L, Fossati S, Porcu M, Mascagni P, Fossati G, Moroni F, Chiarugi A, Neurobiol Dis 2009 36 269 279 10.1016/j.nbd.2009.07.019 19635561
30. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S, Brain Res 2000 857 246 251 10.1016/S0006-8993(99)02439-7 10700573 (Pubitemid 30107811)
31. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. Li Y, Yuan Z, Liu B, Sailhamer EA, Shults C, Velmahos GC, Demoya M, Alam HB, J Trauma 2008 64 863 870 discussion 870-861 10.1097/TA.0b013e318166b822 18404049
32. A critical time window for the survival of neural progenitor cells by HDAC inhibitors in the hippocampus. Kim BW, Yang S, Lee CH, Son H, Mol Cells 2011 31 159 164 10.1007/s10059-011-0019-5 21191817
33. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Magnani M, Crinelli R, Bianchi M, Antonelli A, Curr Drug Targets 2000 1 387 399 10.2174/1389450003349056 11467077
34. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Gottlicher M, EMBO J 2003 22 3411 3420 10.1093/emboj/cdg315 12840003 (Pubitemid 36834871)
35. Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1). Chen WY, Weng JH, Huang CC, Chung BC, Mol Cell Biol 2007 27 7284 7290 10.1128/MCB.00476-07 17709382 (Pubitemid 47549761)
36. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ, Development 1994 120 301 311 8149910
37. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Michaelidis TM, Sendtner M, Cooper JD, Airaksinen MS, Holtmann B, Meyer M, Thoenen H, Neuron 1996 17 75 89 10.1016/S0896-6273(00)80282-2 8755480 (Pubitemid 26251593)
38. bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Gonzalez-Garcia M, Perez-Ballestero R, Ding L, Duan L, Boise LH, Thompson CB, Nunez G, Development 1994 120 3033 3042 7607090
39. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Gonzalez-Garcia M, Garcia I, Ding L, O'Shea S, Boise LH, Thompson CB, Nunez G, Proc Natl Acad Sci USA 1995 92 4304 4308 10.1073/pnas.92.10.4304 7753802
40. Function and expression of the Bcl-x gene in the developing and adult nervous system. Frankowski H, Missotten M, Fernandez PA, Martinou I, Michel P, Sadoul R, Martinou JC, Neuroreport 1995 6 1917 1921 10.1097/00001756-199510020- 00023 8547598
41. Apoptosis and brain development. Roth KA, D'Sa C, Ment Retard Dev Disabil Res Rev 2001 7 261 266 10.1002/mrdd.1036 11754520 (Pubitemid 33108264)
42. Teratogenicity and developmental toxicity of valproic acid in rats. Vorhees CV, Teratology 1987 35 195 202 10.1002/tera.1420350205 3110992 (Pubitemid 17072912)
43. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Schneider T, Przewlocki R, Neuropsychopharmacology 2005 30 80 89 10.1038/sj.npp.1300518 15238991 (Pubitemid 40024402)
44. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Schneider T, Turczak J, Przewlocki R, Neuropsychopharmacology 2006 31 36 46 15920505 (Pubitemid 43250939)
45. The intense world syndrome - an alternative hypothesis for autism. Markram H, Rinaldi T, Markram K, Front Neurosci 2007 1 77 96 10.3389/neuro.01.1.1.006.2007 18982120
46. Minicolumnar pathology in autism. Casanova MF, Buxhoeveden DP, Switala AE, Roy E, Neurology 2002 58 428 432 11839843 (Pubitemid 34150918)
47. Clinical and macroscopic correlates of minicolumnar pathology in autism. Casanova MF, Buxhoeveden DP, Brown C, J Child Neurol 2002 17 692 695 10.1177/088307380201700908 12503647 (Pubitemid 36054407)
48. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS, Chuang DM, FEBS Lett 2003 542 74 78 10.1016/S0014-5793(03)00350-8 12729901 (Pubitemid 36555717)
49. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. Abematsu M, Tsujimura K, Yamano M, Saito M, Kohno K, Kohyama J, Namihira M, Komiya S, Nakashima K, J Clin Invest 2010 120 3255 3266 10.1172/JCI42957 20714104
50. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Gurvich N, Klein PS, Pharmacol Ther 2002 96 45 66 10.1016/S0163- 7258(02)00299-1 12441177 (Pubitemid 35346617)
51. Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate. Creson TK, Yuan P, Manji HK, Chen G, J Mol Neurosci 2009 37 123 134 10.1007/s12031-008-9122-2 18677583
52. Pharmacokinetics of valproic acid and metabolites in mouse plasma and brain following constant-rate application of the drug and its unsaturated metabolite with an osmotic delivery system. Nau H, Zierer R, Biopharm Drug Dispos 1982 3 317 328 10.1002/bdd.2510030405 6819013 (Pubitemid 13217255)
53. Valproate metabolites in the rat brain - regional distribution in various brain areas. Darius J, Meyer FP, Bergstrasser E, Ebermann E, Andreas K, Eur J Drug Metab Pharmacokinet 1999 24 97 104 10.1007/BF03190017 10412898 (Pubitemid 29286650)